Sale by Louis Waldman of 300 shares of Iradimed
| IRMD Stock | USD 52.75 0.64 1.20% |
About 62% of Iradimed's investor base is looking to short. The analysis of overall sentiment of trading Iradimed Co stock suggests that many investors are alarmed at this time. The current market sentiment, together with Iradimed's historical and current headlines, can help investors time the market. In addition, many technical investors use Iradimed stock news signals to limit their universe of possible portfolio assets.
Iradimed |
Filed transaction by Iradimed Corp officer. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Iradimed Fundamental Analysis
We analyze Iradimed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iradimed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iradimed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Iradimed is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Iradimed Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iradimed stock to make a market-neutral strategy. Peer analysis of Iradimed could also be used in its relative valuation, which is a method of valuing Iradimed by comparing valuation metrics with similar companies.
Peers
Iradimed Related Equities
| ANIK | Anika Therapeutics | 3.02 | ||||
| ELMD | Electromed | 1.87 | ||||
| OFIX | Orthofix Medical | 1.58 | ||||
| ITGR | Integer Holdings | 1.46 | ||||
| GKOS | Glaukos Corp | 1.39 | ||||
| SRDX | SurModics | 0.10 | ||||
| SGHT | Sight Sciences | 0.75 | ||||
| CNMD | CONMED | 0.99 | ||||
| LIVN | LivaNova PLC | 2.05 | ||||
| LUNG | Pulmonx Corp | 2.27 | ||||
| KIDS | Orthopediatrics Corp | 2.63 | ||||
| NPCE | Neuropace | 4.32 |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |